Amedisys Inc (NASDAQ: AMED) is 1.07% higher on its value in year-to-date trading and has touched a low of $82.15 and a high of $98.95 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AMED stock was last observed hovering at around $91.91 in the last trading session, with the day’s loss setting it -0.15%.
Currently trading at $91.76, the stock is -0.45% and -0.44% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.13 million and changing -0.16% at the moment leaves the stock -2.14% off its SMA200. AMED registered 0.56% gain for a year compared to 6-month loss of -5.16%. The firm has a 50-day simple moving average (SMA 50) of $92.1632 and a 200-day simple moving average (SMA200) of $93.7621.
The stock witnessed a -1.22% gain in the last 1 month and extending the period to 3 months gives it a -0.24%, and is 0.28% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.16% over the week and 1.17% over the month.
Amedisys Inc (AMED) has around 19000 employees, a market worth around $3.01B and $2.35B in sales. Current P/E ratio is 70.47 and Fwd P/E is 17.80. Profit margin for the company is 1.84%. Distance from 52-week low is 11.70% and -7.27% from its 52-week high. The company has generated returns on investments over the last 12 months (2.83%).
with sales reaching $596.49M over the same period.The EPS is expected to grow by 9.70% this year, but quarterly earnings will post 4.39% year-over-year. Quarterly sales are estimated to grow 4.39% in year-over-year returns.
384.0 institutions hold shares in Amedisys Inc (AMED), with institutional investors hold 93.26% of the company’s shares. The shares outstanding are 32.78M, and float is at 31.96M with Short Float at 7.39%. Institutions hold 91.31% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 3.23 million shares valued at $296.3 million. The investor’s holdings represent 9.8797 of the AMED Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 3.1 million shares valued at $284.69 million to account for 9.4819 of the shares outstanding. The other top investors are ALPINE ASSOCIATES MANAGEMENT INC. which holds 1.28 million shares representing 3.9164 and valued at over $117.59 million, while FIL LTD holds 3.5011 of the shares totaling 1.15 million with a market value of $105.12 million.
Amedisys Inc (AMED) Insider Activity
The most recent transaction is an insider sale by Guidroz Allyson, the company’s Chief Accounting Officer. SEC filings show that Guidroz Allyson sold 2,041 shares of the company’s common stock on Mar 04 ’25 at a price of $92.03 per share for a total of $0.19 million. Following the sale, the insider now owns 8761.0 shares.
Still, SEC filings show that on Nov 07 ’24, North Michael Paul (Former Officer) Proposed Sale 11,221 shares at an average price of $96.80 for $1.09 million. The insider now directly holds shares of Amedisys Inc (AMED).
